Amgen Inc.
Explore Amgen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Amgen Inc.
Explore Amgen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2020 Revenue
$25.4B
Source: Annual report / company filing
Amgen Inc. reported $25.4B in revenue for fiscal year 2020. In 2021, revenue increased to $26.0B.
Steady sales from mature biologics like Enbrel and Prolia.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $36.8B | — | +10.0% |
| FY2024 | $33.4B | $3.8B | +18.6% |
| FY2023 | $28.2B | — | +7.1% |
| FY2022 | $26.3B | — | +1.3% |
| FY2021 | $26.0B | — | +2.2% |
| FY2020 | $25.4B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.